Basilea Pharmaceutica AG
SIX:BSLN
Income Statement
Earnings Waterfall
Basilea Pharmaceutica AG
Revenue
|
157.6m
CHF
|
Cost of Revenue
|
-26.8m
CHF
|
Gross Profit
|
130.8m
CHF
|
Operating Expenses
|
-111.6m
CHF
|
Operating Income
|
19.2m
CHF
|
Other Expenses
|
-8.8m
CHF
|
Net Income
|
10.5m
CHF
|
Income Statement
Basilea Pharmaceutica AG
Dec-2004 | Jun-2005 | Dec-2005 | Jun-2006 | Dec-2006 | Jun-2007 | Dec-2007 | Jun-2008 | Dec-2008 | Jun-2009 | Dec-2009 | Jun-2010 | Dec-2010 | Jun-2011 | Dec-2011 | Jun-2012 | Dec-2012 | Jun-2013 | Dec-2013 | Jun-2014 | Dec-2014 | Jun-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
20
+6 693%
|
30
+55%
|
15
-51%
|
7
-50%
|
7
-9%
|
8
+18%
|
10
+25%
|
12
+19%
|
19
+58%
|
27
+42%
|
68
+154%
|
116
+72%
|
98
-16%
|
67
-32%
|
63
-6%
|
58
-8%
|
47
-19%
|
41
-13%
|
41
-1%
|
42
+4%
|
47
+11%
|
52
+10%
|
57
+10%
|
66
+17%
|
76
+16%
|
102
+33%
|
96
-5%
|
133
+38%
|
123
-7%
|
134
+10%
|
141
+5%
|
128
-9%
|
112
-12%
|
148
+32%
|
152
+2%
|
148
-3%
|
174
+18%
|
158
-9%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(6)
|
(4)
|
1
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(5)
|
(6)
|
(9)
|
(12)
|
(20)
|
(23)
|
(19)
|
(23)
|
(24)
|
(24)
|
(24)
|
(25)
|
(25)
|
(20)
|
(27)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
5
N/A
|
0
N/A
|
6
N/A
|
18
+178%
|
25
+41%
|
66
+163%
|
114
+74%
|
96
-16%
|
64
-33%
|
57
-12%
|
53
-5%
|
48
-10%
|
41
-15%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
27
N/A
|
61
+127%
|
71
+16%
|
92
+31%
|
84
-9%
|
112
+33%
|
99
-11%
|
116
+16%
|
118
+2%
|
104
-12%
|
88
-15%
|
124
+41%
|
126
+2%
|
123
-2%
|
154
+25%
|
131
-15%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(76)
|
(85)
|
(81)
|
(86)
|
(95)
|
(122)
|
(144)
|
(151)
|
(164)
|
(164)
|
(145)
|
(143)
|
(133)
|
16
|
(122)
|
(128)
|
(104)
|
(82)
|
(74)
|
(76)
|
(84)
|
(99)
|
(113)
|
(110)
|
(105)
|
(109)
|
(110)
|
(102)
|
(136)
|
(116)
|
(133)
|
(124)
|
(127)
|
(124)
|
(123)
|
(120)
|
(105)
|
(90)
|
(112)
|
|
Selling, General & Administrative |
(7)
|
(8)
|
(9)
|
(11)
|
(13)
|
(17)
|
(29)
|
(48)
|
(67)
|
(71)
|
(68)
|
(77)
|
(77)
|
(62)
|
(52)
|
(54)
|
(46)
|
(28)
|
(21)
|
(22)
|
(30)
|
(42)
|
(54)
|
(57)
|
(56)
|
(64)
|
(54)
|
(36)
|
(31)
|
(32)
|
(30)
|
(28)
|
(29)
|
(29)
|
(30)
|
(31)
|
(31)
|
(32)
|
(34)
|
|
Research & Development |
(69)
|
(77)
|
(72)
|
(75)
|
(83)
|
(104)
|
(116)
|
(104)
|
(97)
|
(93)
|
(77)
|
(66)
|
(56)
|
(49)
|
(70)
|
(75)
|
(59)
|
(54)
|
(53)
|
(54)
|
(54)
|
(58)
|
(60)
|
(54)
|
(48)
|
(51)
|
(55)
|
(86)
|
(105)
|
(98)
|
(103)
|
(96)
|
(97)
|
(95)
|
(93)
|
(89)
|
(74)
|
(58)
|
(78)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
127
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
6
|
0
|
19
|
0
|
13
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(76)
N/A
|
(65)
+14%
|
(51)
+22%
|
(71)
-40%
|
(88)
-24%
|
(115)
-31%
|
(136)
-19%
|
(142)
-4%
|
(153)
-8%
|
(146)
+4%
|
(120)
+18%
|
(77)
+36%
|
(19)
+75%
|
112
N/A
|
(57)
N/A
|
(72)
-25%
|
(51)
+29%
|
(34)
+33%
|
(33)
+2%
|
(35)
-6%
|
(42)
-18%
|
(52)
-25%
|
(61)
-18%
|
(56)
+8%
|
(44)
+22%
|
(38)
+13%
|
(17)
+55%
|
(18)
-7%
|
(24)
-32%
|
(17)
+30%
|
(17)
-2%
|
(6)
+64%
|
(23)
-278%
|
(36)
-57%
|
1
N/A
|
6
+453%
|
19
+186%
|
64
+248%
|
19
-70%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
1
|
2
|
2
|
3
|
5
|
9
|
11
|
9
|
5
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(6)
|
(7)
|
(7)
|
(7)
|
(7)
|
(6)
|
(6)
|
(6)
|
(7)
|
(8)
|
(8)
|
(8)
|
(10)
|
(11)
|
(10)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
0
|
127
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
15
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(2)
|
0
|
1
|
(0)
|
(0)
|
(2)
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(1)
|
1
|
5
|
4
|
(1)
|
(1)
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
1
|
|
Pre-Tax Income |
(75)
N/A
|
(64)
+15%
|
(50)
+23%
|
(69)
-39%
|
(85)
-24%
|
(110)
-29%
|
(127)
-16%
|
(130)
-3%
|
(144)
-10%
|
(142)
+1%
|
(120)
+15%
|
(78)
+35%
|
108
N/A
|
113
+4%
|
(57)
N/A
|
(72)
-25%
|
(52)
+27%
|
(35)
+33%
|
(33)
+7%
|
(35)
-6%
|
(42)
-18%
|
(52)
-26%
|
(62)
-18%
|
(59)
+3%
|
(51)
+14%
|
(44)
+14%
|
(19)
+56%
|
(21)
-10%
|
(31)
-48%
|
(24)
+23%
|
(22)
+7%
|
3
N/A
|
(15)
N/A
|
(45)
-204%
|
(7)
+85%
|
1
N/A
|
12
+1 304%
|
56
+364%
|
10
-81%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
|
Income from Continuing Operations |
(75)
|
(64)
|
(50)
|
(69)
|
(85)
|
(110)
|
(127)
|
(130)
|
(144)
|
(142)
|
(121)
|
(79)
|
108
|
112
|
(58)
|
(72)
|
(53)
|
(36)
|
(33)
|
(35)
|
(42)
|
(52)
|
(62)
|
(59)
|
(51)
|
(44)
|
(19)
|
(21)
|
(31)
|
(24)
|
(22)
|
3
|
(15)
|
(45)
|
(7)
|
1
|
12
|
56
|
10
|
|
Net Income (Common) |
(75)
N/A
|
(64)
+15%
|
(50)
+23%
|
(69)
-39%
|
(85)
-24%
|
(110)
-29%
|
(127)
-16%
|
(130)
-3%
|
(144)
-10%
|
(142)
+1%
|
(121)
+15%
|
(79)
+34%
|
108
N/A
|
112
+4%
|
(58)
N/A
|
(72)
-25%
|
(53)
+26%
|
(36)
+33%
|
(33)
+8%
|
(35)
-7%
|
(42)
-18%
|
(52)
-26%
|
(62)
-18%
|
(59)
+4%
|
(51)
+14%
|
(44)
+14%
|
(19)
+56%
|
(21)
-10%
|
(31)
-47%
|
(24)
+23%
|
(22)
+7%
|
3
N/A
|
(15)
N/A
|
(45)
-203%
|
(7)
+85%
|
1
N/A
|
12
+1 327%
|
56
+363%
|
10
-81%
|
|
EPS (Diluted) |
-10.93
N/A
|
-8.72
+20%
|
-6.71
+23%
|
-9.06
-35%
|
-11.01
-22%
|
-12.62
-15%
|
-13.42
-6%
|
-13.64
-2%
|
-15.02
-10%
|
-14.86
+1%
|
-12.61
+15%
|
-8.26
+34%
|
11.17
N/A
|
11.71
+5%
|
-6.01
N/A
|
-7.52
-25%
|
-5.54
+26%
|
-3.73
+33%
|
-3.35
+10%
|
-3.39
-1%
|
-4.17
-23%
|
-5.19
-24%
|
-6.09
-17%
|
-5.87
+4%
|
-5.07
+14%
|
-4.05
+20%
|
-1.79
+56%
|
-1.96
-9%
|
-2.89
-47%
|
-2.25
+22%
|
-2.08
+8%
|
0.27
N/A
|
-1.43
N/A
|
-3.85
-169%
|
-0.58
+85%
|
0.08
N/A
|
1.02
+1 175%
|
4.71
+362%
|
0.87
-82%
|